BioTech 365

MAY 4, 2021

Next-Generation Sequencing (NGS) Markets, 2026 by Product & Service (Consumables, Platforms, Services, Bioinformatics), Technology (SBS, SMRT), & Application (Diagnostic, Drug Discovery, Agriculture) – ResearchAndMarkets.com Next-Generation Sequencing (NGS) Markets, 2026 by Product & Service (Consumables, Platforms, Services, Bioinformatics), (..)

Bioinformatics 40

Bioinformatics Production Marketing Drugs 40

Scienmag

DECEMBER 28, 2021

Bioinformatics allows researchers to answer biological questions with advanced computational methods which involves the application of statistics and mathematical modeling. However, the concepts in structural bioinformatics and CADD […].

Bioinformatics 55

Bioinformatics Drugs Scientist Research 55

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. What, then, is the solution?

Development 135

Development Research Drugs Clinical Trials 135

BioTech 365

NOVEMBER 29, 2021

Global Biomarkers Markets, Technology & Competitive Landscape Report 2020-2021 & 2030: Focus on Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics – ResearchAndMarkets.com Global Biomarkers Markets, Technology & Competitive Landscape Report 2020-2021 & 2030: Focus on Proteomics, (..)

Bioinformatics 40

Bioinformatics Clinical Trials Clinical Trials Marketing 40

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . The post Digitalising drug discovery appeared first on.

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

Pharmaceutical Technology

SEPTEMBER 22, 2022

Additionally, the alliance will merge Abpro's DiversImmune and Multimab platforms with Celltrion’s expertise in global biology drug development to progress ABP 102 for treating HER2+ cancers. To create these antibodies, the platform merges next-generation sequencing, nano-immunology, superior engineering and bioinformatics.

Antibody 130

Antibody Development Bioinformatics In-Vitro 130

pharmaphorum

APRIL 1, 2021

AI simulated cell company Turbine is just one of many digital drug discovery firms on the rise in Hungary. We speak to the company’s CEO and co-founder, Szabolcs Nagy, to find out why moving beyond traditional biotech drug development is a good fit for the country’s ecosystem. They go into bioinformatics”. So what do they do?

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

AUGUST 10, 2021

Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma. Dr Timothy Hinks. A major problem is that the disease is so varied, with different biological and clinical manifestations.

Gene Sequencing 116

Gene Sequencing Gene Bioinformatics Genome 116

STAT News

MARCH 6, 2023

Unlike most people who receive medications yet to be cleared by the Food and Drug Administration, none of these patients is getting the vaccines as part of a clinical trial. Instead, the 26 patients paid the foundation to create the vaccines and provide them through the FDA’s expanded access program.

Vaccine 98

Vaccine Vaccination Drugs Clinical Trials 98

XTalks

APRIL 21, 2023

Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS. Ultima Genomics will provide their high-throughput NGS instrument platform, the UG 100, and Genome Insight will provide the bioinformatics platform for data analysis.

Genome 97

Genome Genomics Bioinformatics Genetics 97

Drug Discovery World podcast

MARCH 25, 2022

The articles are called “The benefits of bioinformatics in genomics sequencing” and “LIMs vs ELNs – what does your lab need?”, In the first article, he talks to Lu Rahman and explains the important role of bioinformatics in genomics. . for which Part I and Part II were published separately across DDW issues. . Listen here:

Bioinformatics 52

Bioinformatics Genome Genomics Drugs 52

Scienmag

MAY 19, 2021

Proprietary bioinformatics, paired with comprehensive clinical curation results in reporting that defines clinically actionable, FDA-approved, and clinical trial drug options for the management of the patient’s cancer.

Genome 41

Genome Genomics Bioinformatics FDA Approval 41

Scienmag

OCTOBER 27, 2020

Scientists from the iMolecule group at Skoltech Center for Computational and Data-Intensive Science and Engineering (CDISE) developed BiteNet, a machine learning (ML) algorithm that helps find drug binding sites, i.e. potential drug targets, in proteins. minutes and find optimal spots for drug molecules to attach.

Drugs 59

Drugs Protein Engineer Scientist 59

XTalks

JULY 19, 2021

Phosphorus developed innovations in chemistry, bioinformatics and workflow to design a vertically integrated operating system for clinical genomics within their state-of-the-art CLIA and CAP certified clinical laboratory. Phosphorus is dedicated to making medical-grade technology available at a consumer price point.

Genetics 98

Genetics Genome Genomics Gene 98

pharmaphorum

SEPTEMBER 14, 2020

If you are developing a drug, for example, for infantile epilepsy, then you need to know if your drug target is expressed in the brain and also during early development. Likewise, some patients may have a different version of a gene with respect to people on whom a drug has been tested, which means that drug might not work.”.

Genome 119

Genome Genomics Medicine Gene 119

pharmaphorum

JUNE 10, 2022

Bringing great drugs to the right markets and patients, leveraging the most effective channels to educate and market treatments, and navigating the many incentives of a complex healthcare ecosystem of partners and competitors: all these responsibilities fall squarely on the shoulders of biopharma’s commercial leaders.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

Scienmag

NOVEMBER 9, 2020

Credit: Insilico Tuesday, November 10, 2020 (9AM Beijing) – Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica N.V.

Drugs 53

Drugs Clinical Trials Clinical Trials Medicine 53

Rethinking Clinical Trials

FEBRUARY 28, 2024

Getting study drug and other study materials into the hands of a participant requires distribution via mail or courier, breaking the traditional chain of custody.             Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J.

Clinical Trials 111

Clinical Trials Clinical Trials Trials Clinical Research 111

pharmaphorum

OCTOBER 20, 2021

The system could also have applications in evaluating drugs in clinical trials, helping to gauge if a therapy is having an impact early on in the disease process.

Trials 78

Trials Genome Genomics Bioinformatics 78

pharmaphorum

APRIL 7, 2022

During the initial stage of the collaboration, Ares developed a an AI-powered anti-infectives platform using microbiological lab techniques and bioinformatics that can be used to identify effective antimicrobial compounds or combinations against specific pathogens, which Sandoz can use to inform its “portfolio and commercial decisions.”

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

Scienmag

SEPTEMBER 23, 2020

These molecular insights may foster effective therapies using existing drugs for patients with COVID-19. Credit: UAB BIRMINGHAM, Ala. – Viral and bacterial pathogens wield pathogenic or virulent proteins that interact with high-value targets inside human cells, attacking what is known as the host interactome.

Protein 85

Protein Drugs Bioinformatics Genetics 85

The Pharma Data

DECEMBER 8, 2020

9, 2020 /PRNewswire/ — United Therapeutics Corporation (Nasdaq: UTHR) announced today that the United States Food and Drug Administration (FDA) has granted orphan drug designation to treprostinil for the treatment of patients with idiopathic pulmonary fibrosis (IPF). SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. ,

Drugs 40

Drugs FDA Approval Marketing Containment 40

The Pharma Data

NOVEMBER 25, 2020

Egle has leveraged its unique bioinformatic and translational capabilities to successfully identify targets that will now be pursued under the terms of the alliance. Upon achievement of the target identification, Egle will receive an R&D milestone payment and investment from Takeda. “We

Research 52

Research Bioinformatics Engineer Development 52

Scienmag

MARCH 1, 2021

Screening for predictive factors of drug resistance and tailored therapies can improve outcomes in patients with refractory diffuse large B-cell lymphoma White blood cells or lymphocytes are the soldiers of our immune system that patrol the body via the lymphatic system.

Drugs 75

Drugs Bioinformatics Gene Genetics 75

Scienmag

MARCH 25, 2021

AllianThera Biopharma lead by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases Credit: Insilico Medicine Thursday, 25th of March 2021 (5:00AM EST) — Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing (..)

Medicine 76

Medicine Development Drugs Bioinformatics 76

Scienmag

DECEMBER 29, 2020

Insilico enters into a collaboration with APRINOIA to apply novel generative AI-powered system to discover novel compounds for neurodegenerative diseases Credit: Insilico Wednesday, 30th of December, 2020 (9:00AM, Taipei) – Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to (..)

Medicine 52

Medicine Drugs Research Bioinformatics 52

pharmaphorum

MARCH 28, 2022

AION Labs’ third call for applications seeks computational biologists, bioinformatics and cheminformatics scientists, AI researchers, and antibody or protein engineers at academic and industry research labs worldwide to assemble a fully funded start-up company.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

XTalks

MAY 20, 2022

They also assist in the testing of medical devices and development of drug products. There are different fields to explore as a clinical scientist — these include clinical bioinformatics, physiological sciences, pathology, medical physics and more. Their work might involve matching blood samples for transfusions.

Scientist 105

Scientist Life Science Clinical Research Doctor 105

Scienmag

SEPTEMBER 30, 2020

30, 2020 – Scripps Research chemist Matthew Disney, PhD, and colleagues have created drug-like compounds that, in human cell studies, bind and destroy the pandemic coronavirus’ so-called “frameshifting element” to stop the virus from […].

Engineer 68

Engineer RNA Research Drugs 68

The Pharma Data

MARCH 2, 2021

Over the past four years our two companies have built a strong drug discovery relationship. In this third collaboration, Gubra is responsible for the early discovery of peptides – now applying our proprietary target and drug discovery platform streaMLine.

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52

Scienmag

MARCH 4, 2021

Researchers at Baylor College of Medicine show that analysis of the proteomics, or all the protein data, from aggressive human cancers is a useful approach to identify potential novel therapeutic targets.

Protein 46

Protein Medicine Drugs Research 46

XTalks

DECEMBER 13, 2023

This impressive growth can be attributed to Fulgent’s distinctive chemistries and advanced proprietary bioinformatics pipeline, which have been instrumental in fueling the company’s rapid advancement in recent years. This substantial investment is accelerating the growth of their new drug pipeline. million and $38.8 million and $33.9

Genetics 111

Genetics Vaccination Vaccine DNA 111

Scienmag

APRIL 28, 2021

In the Nature current special issue, the research group published another study on the genome of the common marmoset, an important primate model for neurodegenerative diseases, drug […].

Genomics 64

Genomics Genome Research Drugs 64

The Pharma Data

NOVEMBER 15, 2020

We have fully equipped labs for all stages of drug discovery, including medicinal chemistry, cellular pharmacology, and molecular pharmacology, as well as an “ in silico ” lab for our computational chemistry, bioinformatics, and data mining activities.

Licensing 52

Licensing Licensing Development Research 52

pharmaphorum

MAY 27, 2022

data processing systems that support bioinformatics modelling) and digital record systems (e.g. However, if considered early in the drug development plan, compliance is by no means insurmountable and would be offset by the benefits of digital healthcare tools for patient engagement. video consultations), health data analytics (e.g.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

The Pharma Data

DECEMBER 16, 2020

TWO NOVEL SOLID TUMOUR TARGETS FROM THE PARTNERSHIP TRANSITION INTO DRUG DISCOVERY. Evotec will be responsible for progressing the drug discovery programmes to IND filing. We operate worldwide and our more than 3,400 employees provide the highest quality stand-alone and integrated drug discovery and development solutions.

Protein 40

Protein Bioinformatics Containment Drugs 40

The Pharma Data

SEPTEMBER 11, 2021

“Boehringer Ingelheim believes Twist’s ability to generate potent, diverse therapeutic antibodies by mining its comprehensive libraries, combined with our extensive capabilities and experience in drug discovery and development, will enable us to deliver breakthrough opportunities to patients,” said Clive R. Wood, Ph.D., Leproust, Ph.D.,

Antibody 52

Antibody DNA Containment Manufacturing 52